As a PKC inhibitor, CHE can suppress cell growth and induce apoptosis in a gastric cancer cell line (AGS) by inducing G0/G1 phase arrest, as evaluated by the expressions of p53, p21 (waf/cip1), c-myc, and Bax (Zhu et al., 1999). Here, PRRT2 is linked to gastric cancer.